Lupin, Aurobindo Pharma, Sun Pharma, Infosys and Dr Reddy’s are among the …
CEO Vishal Sikka resigned. Infosys' strategy is now uncertain. What will happen to Dr Sikka's new transformative initiatives? To find out, we'll have to wait until the board finds a new CEO. The stock will be under pressure until then. …
A dozen major investors want Infosys (NASDAQ:INFY) to appoint former CEO Nandan Nilekani to the board to resolve an ongoing feud between the board and the company’s founders, according to Reuters. CEO Vishal Sikka resigned on …
Aug.20 -- Bloomberg Gadfly's Andy Mukherjee takes a look at the departure of Infosys' CEO and what it means for the company. He speaks on "Bloomberg …
CEO Vishal Sikka tried to remake Infosys' culture and service offerings. That led to tension with the company's founders. Infosys, CenturyLink, Cisco and other tech names were struggling Friday alongside troubling news from Washington …
New Delhi: Nandan Nilekani is all set to make a comeback to Infosys, thus providing some stability to the IT major which is going through turbulence in the wake of …
Several large investors have recently added to or reduced their stakes in the company. Kernodle & Katon Asset Management Group LLC purchased a new stake in Infosys Limited during the first quarter worth approximately …
Vishal Sikka has chosen to step down as the CEO of Infosys Ltd ADR due to recent internal drama. This includes letters from the company’s founder, N.R. Narayana Murphy. These letters have criticized the company and specifically called …
"While we do not want to diminish the importance of effective leadership, we nevertheless believe market conditions will remain challenging and will thus likely keep Infosys' stock range bound," he said. Peter Bendor-Samuel, CEO of …